Bacterial Vaginosis. Other inflammation of vagina and vulva
Conditions
Interventions
Intervention 1: Intervention: Administration of Gynophilus Vaginal Capsule, Containing of 341 mg, Twice a Day, For 7 Days. Intervention 2: Control: Administration of Clindamycin Vaginal Gel, One Appl
Treatment - Drugs
Intervention: Administration of Gynophilus Vaginal Capsule, Containing of 341 mg, Twice a Day, For 7 Days.
Control: Administration of Clindamycin Vaginal Gel, One Applicator about to 5 mg, Once a Day, for 7 Days.
Sponsors
Golestan University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Pregnant Women under 20 Weeks` Gestation with Bacterial Vaginosis; Filing the Informed Consent Form; No Vaginal Bleeding. Exclusion Criteria: No Tendency to Participate in the Study after Entering to the Study; Incomplete Consumption of Medications; No Referring for Second or Third Examinations.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence. Timepoint: One Month after Treatment. Method of measurement: AMSEL Criteria.;Cure. Timepoint: One Week after Treatment. Method of measurement: AMSEL Criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Premature Rupture of Membrane. Timepoint: Total Duration of Pregnancy. Method of measurement: Gestational Age Less Than 37 Weeks.;Preterm labor. Timepoint: Total Duration of Pregnancy. Method of measurement: Gestational Age Less Than 37 Weeks.;Neonate`s APGAR score. Timepoint: First and Ffth Minute of Birth. Method of measurement: APGAR Score Table.;Birth Weight of Neonate. Timepoint: After Birth. Method of measurement: Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Soudeh Ramazanpour
Golestan University of Medical Sciences
Outcome results
None listed